Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Prevailing Incidence Of Hematologic Diseases
3.1.2. Advancement In Technologies Of Apheresis Technique
3.1.3. Favorable Reimbursement Policies And Funding For Apheresis Procedures
3.1.4. Growing Geriatric Population
3.2. Key Restraints
3.2.1. Risk Of Blood Contamination While Conducting Transfusions
3.2.2. High Cost Of Investment Associated With Apheresis Procedures

4. Key Analytics
4.1. Impact Of Covid-19 On Apheresis Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entry
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape

5. Market By Procedure
5.1. Plasmapheresis
5.2. Plateletpheresis
5.3. Leukapheresis
5.4. Erythrocytapheresis
5.5. Other Apheresis Procedures

6. Market By Technology
6.1. Centrifugation
6.2. Membrane Separation

7. Market By Product
7.1. Disposable Apheresis Kits
7.2. Apheresis Machine

8. Market By Application
8.1. Hematological Disorders
8.2. Neurological Disorders
8.3. Autoimmune Disorders
8.4. Renal Disorders
8.5. Other Applications

9. Market By End-User
9.1. Blood Banks/ Blood Donation Centers
9.2. Hospitals & Clinics
9.3. Ambulatory Surgical Centers

10. Geographical Analysis
10.1. North America
10.1.1. Market Size & Estimates
10.1.2. Key Growth Enablers
10.1.3. Key Challenges
10.1.4. Key Players
10.1.5. Country Analysis
10.1.5.1. United States
10.1.5.2. Canada

11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Mergers & Acquisitions
11.1.2. Product Launches & Developments
11.1.3. Partnerships & Agreements
11.1.4. Business Expansions, Announcements & Divestitures
11.2. Company Profiles
11.2.1. Asahi Kasei Corporation
11.2.2. Baxter International Inc
11.2.3. B Braun Melsungen Ag
11.2.4. Cerus Corporation
11.2.5. Cytosorbents Corporation
11.2.6. Fresenius Se & Co Kgaa (Fresenius Kabi Ag)
11.2.7. Haemonetics Corporation
11.2.8. Hemacare Corporation
11.2.9. Infomed
11.2.10. Kaneka Corporation
11.2.11. Kawasumi Laboratories Inc
11.2.12. Medicap Clinic Gmbh
11.2.13. Medica Spa
11.2.14. Miltenyi Biotec
11.2.15. Terumo Corporation (Terumo Bct)



List of Figures


Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: North America Apheresis Market, By Procedure, In 2020
Figure 6: North America Apheresis Market, By Plasmapheresis, 2021-2028 (In $ Million)
Figure 7: North America Apheresis Market, By Plateletpheresis, 2021-2028 (In $ Million)
Figure 8: North America Apheresis Market, By Leukapheresis, 2021-2028 (In $ Million)
Figure 9: North America Apheresis Market, By Erythrocytapheresis, 2021-2028 (In $ Million)
Figure 10: North America Apheresis Market, By Other Apheresis Procedures, 2021-2028 (In $ Million)
Figure 11: North America Apheresis Market, By Technology, In 2020
Figure 12: North America Apheresis Market, By Centrifugation, 2021-2028 (In $ Million)
Figure 13: North America Apheresis Market, By Membrane Separation, 2021-2028 (In $ Million)
Figure 14: North America Apheresis Market, By Product, In 2020
Figure 15: North America Apheresis Market, By Disposable Apheresis Kits, 2021-2028 (In $ Million)
Figure 16: North America Apheresis Market, By Apheresis Machine, 2021-2028 (In $ Million)
Figure 17: North America Apheresis Market, By Application, In 2020
Figure 18: North America Apheresis Market, By Hematological Disorders, 2021-2028 (In $ Million)
Figure 19: Prevalence Of Bleeding Disorder In North America, 2019
Figure 20: North America Apheresis Market, By Neurological Disorders, 2021-2028 (In $ Million)
Figure 21: North America Apheresis Market, By Autoimmune Disorders, 2021-2028 (In $ Million)
Figure 22: North America Apheresis Market, By Renal Disorders, 2021-2028 (In $ Million)
Figure 23: North America Apheresis Market, By Other Applications, 2021-2028 (In $ Million)
Figure 24: North America Apheresis Market, By End-User, In 2020
Figure 25: North America Apheresis Market, By Blood Banks/ Blood Donation Centers, 2021-2028 (In $ Million)
Figure 26: North America Apheresis Market, By Hospitals & Clinics, 2021-2028 (In $ Million)
Figure 27: North America Apheresis Market, By Ambulatory Surgical Centers, 2021-2028 (In $ Million)
Figure 28: North America Apheresis Market, Country Outlook, 2020 & 2028 (In %)
Figure 29: United States Apheresis Market, 2021-2028 (In $ Million)
Figure 30: Canada Apheresis Market, 2021-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - APHERESIS
TABLE 2: NORTH AMERICA APHERESIS MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: NORTH AMERICA APHERESIS MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA APHERESIS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: NORTH AMERICA APHERESIS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA APHERESIS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: NORTH AMERICA APHERESIS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA APHERESIS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: NORTH AMERICA APHERESIS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA APHERESIS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: NORTH AMERICA APHERESIS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA APHERESIS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: NORTH AMERICA APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: LEADING PLAYERS OPERATING IN NORTH AMERICA APHERESIS MARKET
TABLE 15: LIST OF MERGERS & ACQUISITIONS
TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 18: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES